ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2016

Jun 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2016-06-23

Reporting Person: Phillips Gary M. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-23	Stock Options (Right to Buy)	$7.61	A	12000	Acquired	2016-06-22	Common Stock (12000)	Direct

Footnotes

F1: This stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan. The option shall vest in equal quarterly installments at the end of each quarter following June 23, 2016, subject to continued service through such dates.